- Thomson Medical Group (SGX:A50) is a regional healthcare group that operates 3 tertiary hospitals with 757 licensed beds in Singapore, Malaysia and Vietnam. It also runs specialist medical clinics and diagnostic imaging centres in Singapore and Malaysia.
- - Read this at SGinvestors.io -
Key Highlights
Malaysian operations are the key growth engine.
- Bursa-listed TMC Life Sciences Bhd (TLS) has enjoyed strong growth since FY20, led by increased bed count, higher patient load, and bigger bill size with a larger scope of treatment.
- - Read this at SGinvestors.io -
Franco-Vietnam Hospital extends Thomson Medical’s geographical reach
- Franco-Vietnam Hospital extends Thomson Medical’s geographical reach to the burgeoning economies of Vietnam, Cambodia, and Laos, with a combined population of 120mil. A full-year contribution from Franco-Vietnam Hospital in FY25e could lift EBITDA to 12.6% above that of FY23.
- Founded in 2003, Franco-Vietnam Hospital is one of Vietnam's six Joint Commission International (JCI) accredited hospitals. It has 200 doctors offering more than 30 specialties. Franco-Vietnam Hospital is adding a new wing to raise floor space by 33% from FY26e.
Expect a dip in FY24e net profit.
- Read more at SGinvestors.io.
Above is the excerpt from report by Phillip Securities Research.
Clients of Phillip Capital may be the first to access the full report in PDF @ https://www.stocksbnb.com/.
Peggy Mak Phillip Securities Research | https://www.stocksbnb.com/ 2024-03-25
Previous report by Phillip:
2020-02-03 Thomson Medical Group - Credit View.
Price targets by other brokers at Thomson Medical Target Prices.
Listing of research reports at Thomson Medical Analyst Reports.
Relevant links:
Thomson Medical Share Price History,
Thomson Medical Announcements,
Thomson Medical Dividends & Corporate Actions,
Thomson Medical News Articles
